More than 140 million Americans use artificial sweeteners, a habit driven by the irrefutable fact that excess sugar is harmful. But I'm continually amazed by alarmist headlines on the topic.
In May, the World Health Organization (WHO) released a report to support its "conditional recommendation" against the use of non-sugar sweeteners (NSS) for weight control. Despite its goal "to provide evidence-informed guidance," the WHO report includes the disclaimer that "The recommendation is based on evidence of low certainty."
Low certainty is an accurate descriptor for the findings of many of the 280-plus studies in the report. That the guidance does not apply to patients with diabetes was easily lost in the repeated mentions of the perceived dangers of these sugar alternatives.
The review included various table-top and beverage sweeteners, including acesulfame K, aspartame, saccharin, sucralose, stevia, and stevia derivatives. Low-calorie sugars and sugar alcohols such as erythritol were excluded.
WHO looked at long- and short-term trials, randomized controlled trials (RCTs), prospective studies, and case-control studies measuring a wide range of endpoints, from dental caries to cancer. The report highlighted that some findings cannot be attributed directly to NSS use but may simply be due to their substitution for sugar. Differences in outcomes due to sex, ethnicity, and body weight status could not be assessed either.
COMMENTARY
In Defense of Artificial Sweeteners
Melissa Walton-Shirley, MD
DisclosuresJune 26, 2023
More than 140 million Americans use artificial sweeteners, a habit driven by the irrefutable fact that excess sugar is harmful. But I'm continually amazed by alarmist headlines on the topic.
In May, the World Health Organization (WHO) released a report to support its "conditional recommendation" against the use of non-sugar sweeteners (NSS) for weight control. Despite its goal "to provide evidence-informed guidance," the WHO report includes the disclaimer that "The recommendation is based on evidence of low certainty."
Low certainty is an accurate descriptor for the findings of many of the 280-plus studies in the report. That the guidance does not apply to patients with diabetes was easily lost in the repeated mentions of the perceived dangers of these sugar alternatives.
The review included various table-top and beverage sweeteners, including acesulfame K, aspartame, saccharin, sucralose, stevia, and stevia derivatives. Low-calorie sugars and sugar alcohols such as erythritol were excluded.
WHO looked at long- and short-term trials, randomized controlled trials (RCTs), prospective studies, and case-control studies measuring a wide range of endpoints, from dental caries to cancer. The report highlighted that some findings cannot be attributed directly to NSS use but may simply be due to their substitution for sugar. Differences in outcomes due to sex, ethnicity, and body weight status could not be assessed either.
Credits:
Lead image: Mirror Images/Dreamstime
Image 1: Billy Blume/Dreamstime
Image 2: David Tonelson/Dreamstime
© 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: In Defense of Artificial Sweeteners - Medscape - Jun 26, 2023.
Tables
Authors and Disclosures
Authors and Disclosures
Author
Melissa Walton-Shirley, MD
Clinical Cardiologist, Nashville, Tennessee
Disclosure: Melissa Walton-Shirley, MD, has disclosed no relevant financial relationships.